Blood Flow Restriction Exercise for Multiple Sclerosis
(BRAVe-MS Trial)
Trial Summary
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have had changes to your MS-related drug therapy in the month before joining, you may not be eligible.
Research suggests that blood flow restriction training, combined with low-intensity resistance training, can help people with multiple sclerosis improve strength without increasing fatigue. This approach has shown similar benefits to traditional exercise in healthy individuals and may be feasible for those with advanced MS.
12345Blood flow restriction exercise, which involves using a cuff to partially restrict blood flow during low-intensity exercise, has been used safely in healthy populations and may help improve strength without increasing fatigue in people with multiple sclerosis. However, its effects on blood pressure and cardiovascular response need further study, especially in different populations.
13467Blood flow restriction exercise is unique because it combines low-intensity resistance training with a special cuff that partially restricts blood flow, allowing people with multiple sclerosis to improve strength without increasing fatigue, unlike traditional high-intensity exercises.
12345Eligibility Criteria
This trial is for Veterans aged 18-75 with a confirmed MS diagnosis who need assistance to walk or use a wheelchair but can sit in one for over an hour. They should not have severe cognitive issues, recent blood clots, extremely high blood pressure, intense leg muscle stiffness, or be on certain MS treatments.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo low-load resistance training with or without blood flow restriction for 10 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment